{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T06:50:53Z","timestamp":1672728653076},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jtho.2016.09.136","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T14:15:16Z","timestamp":1477404916000},"page":"249-257","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Case-Control Study: Smoking History Affects the Production of Tumor Antigen\u2013Specific Antibodies NY-ESO-1 in Patients with Lung Cancer in Comparison with Cancer Disease\u2013Free Group"],"prefix":"10.1016","volume":"12","author":[{"given":"Dagmar","family":"My\u0161\u00edkov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Adkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nad'a","family":"Hradilov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ond\u0159ej","family":"Palata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"\u0160imonek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u0159\u00ed","family":"Pozniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Kola\u0159\u00edk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Skallov\u00e1-Fialov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radek","family":"\u0160p\u00ed\u0161ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Lischke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2016.09.136_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jtho.2016.09.136_bib2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/bmj.2.4682.739","article-title":"Smoking and carcinoma of the lung; preliminary report","volume":"2","author":"Doll","year":"1950","journal-title":"BMJ"},{"key":"10.1016\/j.jtho.2016.09.136_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/bph.13198","article-title":"COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link","volume":"173","author":"Bozinovski","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jtho.2016.09.136_bib4","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/0002-9343(92)90621-H","article-title":"Smoking and cancer","volume":"93","author":"Carbone","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.jtho.2016.09.136_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12307-016-0183-4","article-title":"Review: the contribution of both nature and nurture to carcinogenesis and progression in solid tumours","volume":"9","author":"Hyndman","year":"2016","journal-title":"Cancer Microenviron"},{"key":"10.1016\/j.jtho.2016.09.136_bib6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.ejca.2012.03.007","article-title":"Lung cancer in never smokers\u2014a review","volume":"48","author":"Couraud","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtho.2016.09.136_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10147-010-0160-8","article-title":"Non-small cell lung cancer in never smokers as a representative\u00a0\u2018non-smoking-associated lung cancer': epidemiology and clinical features","volume":"16","author":"Yano","year":"2011","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.jtho.2016.09.136_bib8","doi-asserted-by":"crossref","first-page":"721531","DOI":"10.1155\/2010\/721531","article-title":"Prognostic and diagnostic value of spontaneous tumor-related antibodies","volume":"2010","author":"Kobold","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jtho.2016.09.136_bib9","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00262-009-0733-4","article-title":"A\u00a0systematic review of humoral immune responses against tumor antigens","volume":"58","author":"Reuschenbach","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jtho.2016.09.136_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.lungcan.2013.10.008","article-title":"Audit of the autoantibody test, EarlyCDT(R)-lung, in 1600 patients: an evaluation of its performance in routine clinical practice","volume":"83","author":"Jett","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2016.09.136_bib11","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s13277-012-0379-2","article-title":"EarlyCDT(R)-Lung test: improved clinical utility through additional autoantibody assays","volume":"33","author":"Chapman","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jtho.2016.09.136_bib12","doi-asserted-by":"crossref","first-page":"46121","DOI":"10.18632\/oncotarget.10028","article-title":"Expression of tumor antigen on primary ovarian cancer cells compared to established ovarian cancer cell lines","volume":"7","author":"Kloudova","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtho.2016.09.136_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-60327-811-9_2","article-title":"Autoantibodies against cancer antigens","volume":"520","author":"Gnjatic","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jtho.2016.09.136_bib14","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3892\/etm.2014.1913","article-title":"Measurement of serum antibodies against NY-ESO-1 by ELISA: a guide for the treatment of specific immunotherapy for patients with advanced colorectal cancer","volume":"8","author":"Long","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jtho.2016.09.136_bib15","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.187.8.1349","article-title":"A\u00a0survey of the humoral immune response of cancer patients to a panel of human tumor antigens","volume":"187","author":"Stockert","year":"1998","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jtho.2016.09.136_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lungcan.2013.01.002","article-title":"Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer","volume":"80","author":"Okamura","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2016.09.136_bib17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/thx.2007.083592","article-title":"Autoantibodies in lung cancer: possibilities for early detection and subsequent cure","volume":"63","author":"Chapman","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jtho.2016.09.136_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.canlet.2005.05.008","article-title":"Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1","volume":"236","author":"Tureci","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jtho.2016.09.136_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0169-5002(03)00244-7","article-title":"Expression of cancer\/testis (CT) antigens in lung cancer","volume":"42","author":"Tajima","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2016.09.136_bib20","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.1158\/1078-0432.CCR-05-1203","article-title":"Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer","volume":"11","author":"Gure","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2016.09.136_bib21","first-page":"1063","article-title":"The relationship between NY-ESO-1 mRNA expression and clinicopathological features in non-small cell lung cancer","volume":"11","author":"Konishi","year":"2004","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jtho.2016.09.136_bib22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3892\/ijmm.2012.896","article-title":"Pattern of cancer\/testis antigen expression in lung cancer patients","volume":"29","author":"Kim","year":"2012","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jtho.2016.09.136_bib23","first-page":"1089","article-title":"Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance","volume":"28","author":"Yoshida","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jtho.2016.09.136_bib24","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1002\/ijc.21669","article-title":"Expression of multiple epigenetically regulated cancer\/germline genes in nonsmall cell lung cancer","volume":"118","author":"Grunwald","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jtho.2016.09.136_bib25","first-page":"4631","article-title":"The prognostic significance of HER2 overexpression in non-small cell lung cancer","volume":"31","author":"Takenaka","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jtho.2016.09.136_bib26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.lungcan.2014.12.018","article-title":"Targeting HER2 in the treatment of non-small cell lung cancer","volume":"87","author":"Mar","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2016.09.136_bib27","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1182\/blood-2004-09-3707","article-title":"NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses","volume":"105","author":"van Rhee","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtho.2016.09.136_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(06)95001-5","article-title":"NY-ESO-1: review of an immunogenic tumor antigen","volume":"95","author":"Gnjatic","year":"2006","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.jtho.2016.09.136_bib29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2217\/imt.15.3","article-title":"New York esophageal squamous cell carcinoma-1 and cancer immunotherapy","volume":"7","author":"Esfandiary","year":"2015","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jtho.2016.09.136_bib30","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1128\/MCB.19.11.7327","article-title":"DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with\u00a0a\u00a0CpG-rich promoter","volume":"19","author":"De Smet","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jtho.2016.09.136_bib31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/1479-5876-9-192","article-title":"Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas\/Fas ligand pathway","volume":"9","author":"Konkankit","year":"2011","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jtho.2016.09.136_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.lungcan.2009.05.010","article-title":"Clinical significance of cancer\/testis antigens expression in patients with non-small cell lung cancer","volume":"68","author":"Shigematsu","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2016.09.136_bib33","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/thorax.58.9.803","article-title":"Chronic obstructive pulmonary disease * 12: new treatments for COPD","volume":"58","author":"Barnes","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.jtho.2016.09.136_bib34","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.1994.03520190043033","article-title":"Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study","volume":"272","author":"Anthonisen","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jtho.2016.09.136_bib35","first-page":"12","article-title":"Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6)","volume":"6","author":"Cho","year":"2006","journal-title":"Cancer Immun"},{"key":"10.1016\/j.jtho.2016.09.136_bib36","doi-asserted-by":"crossref","first-page":"8496","DOI":"10.1016\/j.vaccine.2011.09.014","article-title":"MAGE-A family: attractive targets for cancer immunotherapy","volume":"29","author":"Sang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jtho.2016.09.136_bib37","first-page":"7959","article-title":"Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis","volume":"61","author":"Jang","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2016.09.136_bib38","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1158\/0008-5472.CAN-05-3327","article-title":"Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis","volume":"66","author":"Peikert","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2016.09.136_bib39","first-page":"731","article-title":"Immunohystochemical expression of cancer\/testis antigens (MAGE-A3\/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features","volume":"32","author":"Grah","year":"2008","journal-title":"Coll Antropol"},{"key":"10.1016\/j.jtho.2016.09.136_bib40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ijc.22309","article-title":"Cancer\/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer","volume":"120","author":"Groeper","year":"2007","journal-title":"Int J Cancer"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086416311765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086416311765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T04:21:47Z","timestamp":1536294107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086416311765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1556086416311765"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2016.09.136","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Case-Control Study: Smoking History Affects the Production of Tumor Antigen\u2013Specific Antibodies NY-ESO-1 in Patients with Lung Cancer in Comparison with Cancer Disease\u2013Free Group","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2016.09.136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}